In a meeting with the Ministry of Science and Technology last month, Prime Minister Pham Minh Chinh opined that “it is necessary to design appropriate institutions, mechanisms, and policies.
According to State media, China has built new plant for IMBCAMS COVID-19 vaccine to multiply the production and develop upto 1 billion shots of one of the seven approved vaccines for use in China. China has aimed to vaccinate 40% of its population by the end of June.
DST funded start-up s ELISA test to better estimate COVID 19 antibody concentration ANI | Updated: May 22, 2021 11:00 IST
The ministry in an official statement said that it was a Bangalore-based start-up that developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples. The handheld device provides the results within five minutes. PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies. While Qualitative analysis detects constituent elements in the sample, the semiquantitative analysis gives an approximate estimation of their concentrations. PathShodh has received the license to manufacture for sale from t
New Delhi [India], May 21 (ANI): The Department of Science and Technology has invited applications from startups and companies for developing new technologies and innovative products to tackle the second wave of Covid-19.
India News: "The current production capacity of indigenously developed Covaxin will be doubled by May-June 2021 and then increased nearly 6-7 fold by July - Augus